BAM
TMO icon

Bell Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bell Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.05M Sell
12,077
-194
-2% -$93.1K 1.62% 11
2026
Q1 		$6.05M Buy
12,271
+3,562
+41% +$1.93M 1.78% 9
2025
Q4 		$5.07M Buy
8,709
+1,243
+17% +$703K 1.36% 21
2025
Q3 		$3.62M Sell
7,466
-2,274
-23% -$1.06M 0.99% 39
2025
Q2 		$3.95M Buy
9,740
+488
+5% +$204K 0.87% 51
2025
Q1 		$4.6M Sell
9,252
-1,620
-15% -$877K 0.85% 57
2024
Q4 		$5.66M Sell
10,872
-98
-0.9% -$53.9K 1.03% 42
2024
Q3 		$6.79M Sell
10,970
-4,128
-27% -$2.44M 1.24% 29
2024
Q2 		$8.35M Sell
15,098
-109
-0.7% -$62.4K 1.17% 32
2024
Q1 		$8.84M Sell
15,207
-41
-0.3% -$23K 1.3% 37
2023
Q4 		$8.09M Buy
15,248
+1
+0% +$484 1.23% 40
2023
Q3 		$7.72M Buy
15,247
+3,268
+27% +$1.74M 1.27% 41
2023
Q2 		$6.25M Buy
+11,979
New +$6.46M 1.07% 52

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bell Asset Management's TMO Position: Q2 2026 in Review

Bell Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 1.6% in Q2 2026, selling an estimated $93.1K and leaving 12,077 shares worth $6.05M. The position accounts for 1.62% of the portfolio, ranked #11.

Bell Asset Management first reported a position in TMO in Q2 2023 and has held it in 13 quarters since. The position peaked at $8.84M in Q1 2024. 2,624 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bell Asset Management held 12,077 shares of Thermo Fisher Scientific worth $6.05M as of Q2 2026.
  • Bell Asset Management sold 194 Thermo Fisher Scientific shares in Q2 2026, an estimated $93.1K.
  • Thermo Fisher Scientific made up 1.62% of Bell Asset Management's portfolio in Q2 2026, its #11 holding.
  • Bell Asset Management first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 13 quarters since.
  • Bell Asset Management's Thermo Fisher Scientific position peaked at $8.84M in Q1 2024.
  • 2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bell Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.